Skip to content

Artiva Biotherapeutics, Inc. ARTV Prepaid & Other Current

Prepaid & Other Current at other companies

Gilead Sciences logo
Gilead SciencesGILD
$4.34B+53.5%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$5.28M+5.6%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$6.41M-44.4%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$1.7M+97.6%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$9.52M-31.7%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$20.44M+81.2%

Other financials

Income statement

See full
Revenue-
Operating income-$24.4M-10.2%
Net income-$23.5M-15.8%
EPS (diluted)-$0.95-14.5%

Balance sheet

See full
Cash & equivalents$21.4M-30.6%
Total debt$10.3M-26.7%
Total equity$87.8M-48.0%
Total assets$106.0M-44.6%

Cash flow

See full
Operating cash flow-$21.0M-5.6%
CapEx$242.0K-52.6%
Free cash flow-$21.2M-4.1%

Valuation

See full
Market cap$429.03M+1,015%
Enterprise value$417.88M+1,832%

Profitability

See full
Operating margin-83.9%
Net margin-79.3%

Returns & leverage

See full
Return on equity-67.9%
Debt / equity0.1×0.0×
Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s prepaid & other current?
Artiva Biotherapeutics, Inc. (ARTV) reported prepaid & other current of $1.96M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s prepaid & other current changed year-over-year?
Artiva Biotherapeutics, Inc.'s prepaid & other current decreased by 48.6% year-over-year, from $3.81M to $1.96M.
What is the long-term trend for Artiva Biotherapeutics, Inc.'s prepaid & other current?
Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s prepaid & other current has grown at a 105.0% compound annual growth rate (CAGR), from $1.09M to $4.59M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.